RT Journal Article
SR Electronic
T1 Metabolomics insights into osteoporosis through association with bone mineral density
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.16.21249919
DO 10.1101/2021.01.16.21249919
A1 Zhang, Xiaoyu
A1 Xu, Hanfei
A1 Li, Gloria H. Y.
A1 Long, Michelle T.
A1 Cheung, Ching-Lung
A1 Vasan, Ramachandran S.
A1 Hsu, Yi-Hsiang
A1 Kiel, Douglas P.
A1 Liu, Ching-Ti
YR 2021
UL http://medrxiv.org/content/early/2021/01/20/2021.01.16.21249919.abstract
AB Osteoporosis, a disease characterized by low bone mineral density (BMD), increases the risk for fractures. Conventional risk factors alone do not completely explain measured BMD or osteoporotic fracture risk. Metabolomics may provide additional information. We aim to identify BMD-associated metabolomic markers that are predictive of fracture risk. We assessed 209 plasma metabolites by LC-MS/MS in 1,552 Framingham Offspring Study participants, and measured femoral neck (FN) and lumbar spine (LS) BMD 2-10 years later using dual energy x-ray absorptiometry. We assessed osteoporotic fractures up to 27-year follow-up after metabolomic profiling. We identified twenty-seven metabolites associated with FN-BMD or LS-BMD by LASSO regression with internal validation. Incorporating selected metabolites significantly improved the prediction and the classification of osteoporotic fracture risk beyond conventional risk factors (AUC=0.74 for the model with identified metabolites and risk factors vs AUC=0.70 with risk factors alone, p=0.001; Net reclassification index=0.07, p=0.03). We replicated significant improvement in fracture prediction by incorporating selected metabolites in 634 participants from the Hong Kong Osteoporosis Study (HKOS). The glycine, serine, and threonine metabolism pathway (including four identified metabolites: creatine, dimethylglycine, glycine, and serine) was significantly enriched (FDR p-value=0.028). Furthermore, three causally related metabolites (glycine, Phosphatidylcholine [PC], and Triacylglycerol [TAG]) were negatively associated with FN-BMD while PC and TAG were negatively associated with LS-BMD through Mendelian randomization analysis. In summary, metabolites associated with BMD are helpful in osteoporotic fracture risk prediction. Potential causal mechanisms explaining the three metabolites on BMD are worthy of further experimental validation. Our findings may provide novel insights into the pathogenesis of osteoporosis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partly supported by NHLBI/NIH Framingham Heart Study contract numbers: NO1-HC-25195 (RSV), HHSN268201500001I (RSV), & 75N92019D00031 (RSV), NIDDK/NIH R01 DK081572 (RSV), NIAMS/NIH R01 AR041398 (DPK, CTL), NIAM/NIH R01 AR072199 (YHH, HX, CTL), Doris Duke Charitable Foundation (XZ, MTL, CTL), the Evans Medical Foundation and the Jay and Louis Coffman Endowment from the Department of Medicine, Boston University School of Medicine (RSV).The replication study is supported by Early Career Scheme (27110416) funded by the Research Grants Council, HKSAR, China.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All participants provided written informed consent and the study protocol was approved by the Hebrew SeniorLife and Boston University Medical Campus institutional review boards.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesFramingham Cohort data is available in dbGaP.